Maplight Therapeutics, Inc. · NASDAQ:MPLT

Foff Erin Pennock sold 50,280 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 4 to May 6, 2026 · Filed May 6, 2026

From May 4 to May 6, 2026, Foff Erin Pennock (Chief Medical Officer) sold 50,280 Maplight Therapeutics, Inc. shares at an average US$28.39 for US$1.43M under a trading plan, leaving 350,497 shares. Filed May 6, 2026 (Form 4).

Sold
50,280 shares
Price
US$28.39 average (US$27.50 to US$30.08)
Value
US$1.43M
Holding after
350,497 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Voting Common StockSale9,180US$27.50391,597Direct
May 4, 2026Voting Common StockSale5,460US$28.37386,137Direct
May 4, 2026Voting Common StockSale312US$29.56385,825Direct
May 4, 2026Voting Common StockSale700US$30.08385,125Direct
May 5, 2026Voting Common StockSale9,645US$28.12375,480Direct
May 5, 2026Voting Common StockSale931US$29.00374,549Direct
May 6, 2026Voting Common StockSale8,152US$28.04366,397Direct
May 6, 2026Voting Common StockSale15,900US$29.13350,497Direct

Source

View original at SEC

Related